STING-dependent Intestinal Regeneration upon Radiation Injury
STING-dependent Intestinal Regeneration upon Radiation Injury
批准号:
10386172
负责人:
Jian Yu
金额:
$50.13万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-07 至 2027-01-31
关键词:
3-DimensionalATAC-seqAbdomenAcuteAdultBone MarrowCancer PatientCell DeathCellsCessation of lifeChemotherapy and/or radiationChronicCoupledDNA DamageDataDissectionDoseDose-LimitingEpithelialExcisionFDA approvedFRAP1 geneFunctional disorderGastrointestinal InjuryGenetically Engineered MouseHealthHourHumanImageImmuneImmune TargetingImmune signalingImpairmentInflammationInterferonsIntestinesKnowledgeLGR5 geneLeadLongevityMediatingMitoticModelingMolecular AnalysisMucosal ImmunityMusMutagensNatural regenerationNormal tissue morphologyOrganoidsPaneth CellsPathway interactionsPlayPreventionProductionQuality of lifeRadiationRadiation InjuriesRecoveryRoleSignal TransductionStimulator of Interferon GenesSurvivorsTP53 geneTestingTherapeuticTissuesWhole-Body IrradiationWorkcell injurychemokinedysbiosisenteritisepigenomicsimprovedin vivoinjury recoveryinsightintestinal barrierintestinal epitheliumintestinal injuryirradiationmouse modelnovelpreservationpublic health relevanceradiation recoveryreceptorrepairedresponsestem cell divisionstem cell nichestem cell self renewalstem cellssystemic inflammatory responsetherapeutic targettooltranscriptome sequencingtranscriptomics
中文摘要
总结
肠上皮是快速更新的成体组织,对遗传毒性剂高度敏感,
放疗和化疗急性胃肠道(GI)损伤可能是致命的辐射受害者或剂量限制
在癌症患者中,这可能导致慢性屏障功能障碍,损害幸存者的生活质量。
放射性肠炎最早是在1897年被描述的,当时还没有FDA批准的治疗方法,部分原因是
这是由于对肠干细胞(ISC)损伤如何与再生相结合的理解有限。我们和其他人
已经建立了细胞内在p53途径控制ISC肠再生,使用高剂量的总
全身照射(TBI)和腹部照射(ABI)(保留大部分骨髓)模型。我们最近的数据
表明包括先天免疫信号在内的“小生境”信号在肠再生中的新作用。我们
表明高度暂时和动态的急性和局部炎症是“修复性的”,
通过干扰素基因刺激因子(STING)依赖性1型干扰素(IFN)反应,
促进肠道再生。令人惊讶的是,非骨髓(BM)STING在急性白血病中起主要作用。
隐窝炎症和再生。值得注意的是,在TBI或TBI后48小时给予IFNβ单次给药,
ABI改善了STING缺陷小鼠和WT小鼠的存活率和肠道再生。这些数据支持
IFNβ的诱导性产生对于促进ISC和肠屏障的恢复是必要的和充分的,
辐射损伤通过一种新的生态位和免疫依赖机制。我们将用三个来检验这个假设
使用体内和离体小鼠和人类肠道类器官的特定目的,
解剖SA 1.解剖急性隐窝再生中STING依赖的局部IFNβ产生。SA 2.阐明
用于ISC再生的STING依赖性免疫靶标。SA 3.建立IFNβ作为一种新的靶点,
放射损伤后肠黏膜屏障功能恢复。这些研究将提供新的
通过上皮和免疫相互作用,
生态位,并建立时间STING/IFNβ信号传导作为一种新的和正常的组织选择性靶点,以治疗
辐射引起的急性肠道损伤
英文摘要
Summary
The intestinal epithelium is the fast renewing adult tissue and highly sensitive to genotoxic agents such as
radiation and chemotherapy. Acute gastrointestinal (GI) injury can be lethal in radiation victims or dose-limiting
in cancer patients, which can lead to chronic barrier dysfunctions that impair the quality of life in survivors.
Radiation induced enteritis was first described in 1897, while there is still no FDA-approved treatment, in part
due to limited understanding of how intestinal stem cell (ISC) injury is coupled to regeneration. We and others
have established that the cell-intrinsic p53 pathway governs ISC intestinal regeneration using high dose total
body irradiation (TBI) and abdominal irradiation (ABI) (with major bone marrow sparing) models. Our recent data
indicate a novel role of “Niche” signals including innate immune signaling in intestinal regeneration. We
demonstrated that a highly temporal and dynamic acute and local inflammation is “reparative”, which is activated
by Stimulator of Interferon Genes (STING)-dependent Type 1 Interferon (IFN) response following delayed mitotic
death to promote intestinal regeneration. Surprisingly, non-bone marrow (BM) STING plays a major role in acute
crypt inflammation and regeneration. Remarkably, a single administration of IFNβ given 48 hours after TBI or
ABI improved survival and intestinal regeneration in STING-deficient mice and WT mice. These data support
that inducible production of IFNβ is necessary and sufficient to promote ISC and intestinal barrier recovery from
radiation injury through a novel niche and immune-dependent mechanism. We will test this hypothesis with three
specific aims using in vivo and ex vivo mouse and human intestinal organoids coupled with in depth mechanistic
dissection. SA1. Dissect STING-dependent local IFNβ production in acute crypt regeneration. SA2. Elucidate
STING-dependent immune targets for ISC regeneration. SA3. Establish IFNβ as a novel target to enhance long-
term ISC and intestinal barrier recovery from radiation injury. The proposed studies will provide novel
mechanistic insights in radiation-induced ISC regeneration through epithelial and immune interactions in the
niche, and establish temporal STING/IFNβ signaling as a novel and normal tissue selective target to treat
radiation-induced acute intestinal damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting defective necroptosis in colorectal cancer
-
批准号:10307591
-
项目类别:
-
资助金额:$43.07万
-
财政年份:2019
-
负责人:Jian Yu
-
依托单位:
Targeting defective necroptosis in colorectal cancer
-
批准号:10054976
-
项目类别:
-
资助金额:$44.34万
-
财政年份:2019
-
负责人:Jian Yu
-
依托单位:
Targeting defective necroptosis in colorectal cancer
-
批准号:9914466
-
项目类别:
-
资助金额:$46.14万
-
财政年份:2019
-
负责人:Jian Yu
-
依托单位:
Translation addiction and targeting in colon cancer
-
批准号:10063486
-
项目类别:
-
资助金额:$46.92万
-
财政年份:2018
-
负责人:Jian Yu
-
依托单位:
Translation addiction and targeting in colon cancer
-
批准号:10317055
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2018
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8534110
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8700642
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8134688
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8328970
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:7935368
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8495594
-
项目类别:
-
资助金额:$6.56万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8895629
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8133541
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:8318944
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21
-
批准号:7791529
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Jian Yu
-
依托单位:
Role of PUMA in EGFR targeted therapy in HNSCC
-
批准号:7816921
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:Jian Yu
-
依托单位:
Role of PUMA in EGFR targeted therapy in HNSCC
-
批准号:8076394
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2008
-
负责人:Jian Yu
-
依托单位:
Role of PUMA in EGFR targeted therapy in HNSCC
-
批准号:7620091
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:Jian Yu
-
依托单位:
Role of PUMA in EGFR targeted therapy in HNSCC
-
批准号:7514220
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:Jian Yu
-
依托单位:
Role of PUMA in EGFR targeted therapy in HNSCC
-
批准号:8270359
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2008
-
负责人:Jian Yu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位: